Mazzo Muses On The FDA, Google & Failing Fast
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 001″]
Jim Mazzo, Chairman and CEO of AcuFocus, offers his insights on why ophthalmology remains a standout sector in life sciences and what investors and entrepreneurs need to do to find success in Medtech. Also, what should we make of Google’s contact lens deal with Novartis?
Podcast Guest
Jim Mazzo
Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in presbyopia correction and is known for its revolutionary KAMRA inlay which was recently FDA approved. Mr. Mazzo is also the Executive Chairman for Neurotech Pharmaceuticals is a biotechnology company developing sight-saving therapies for retinal diseases.